Alnylam Pharmaceuticals
Senior Advisor to the healthcare team of New Enterprise Associates; former Executive Vice President and Director of Bristol-Myers Squibb, where he also served as Chief Scientific officer and President of R&D; Co-chair of the Scientific Advisory Board of Amgen; Member of Scientific Steering Committee for the Sean Parker Institute for Cancer Immunotherapy and member of the Board of Directors for Adaptimmune, Vir Biotechnology and Surface Oncology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Alnylam Pharmaceuticals
29 followers
Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.